AI Won’t Replace Clinical Trial Teams, But It Fixes the Bottlenecks That Keep Patients Out - MedCity News
Clinical trials often fail due to difficulties in identifying eligible patients, not a lack of willingness to participate. AI can help overcome this bottleneck by efficiently analyzing unstructured medical data to identify potential participants, thus transforming recruitment from a reactive to a proactive process without replacing human judgment.
The most valuable insight for you is that AI can significantly transform clinical trial recruitment by analyzing large volumes of unstructured clinical data to identify eligible patients who are often overlooked, thereby shifting from a reactive to a proactive recruitment process. This application of AI not only accelerates patient identification but also engages potential participants immediately, enhancing both the efficiency and inclusivity of trials. For someone tracking AI in drug discovery and clinical operations, this highlights a crucial area where AI can create substantial operational efficiencies and expand patient access to research opportunities.